Company Profile

Solenic Medical Inc
Profile last edited on: 3/9/23      CAGE: 89D02      UEI: H5F1MMEAMCM3

Business Identifier: Non-invasive treatment of infected metallic implants in body
Year Founded
2019
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

501 Graham Road
College Station, TX 77845
   (479) 571-2592
   info@solenic.com
   www.solenic.com
Location: Single
Congr. District: 17
County: Brazos

Public Profile

Solenic Medical is structured around development of a medical device designed to provide non-invasive treatment for infected metallic implants in the body. Using alternating magnetic fields (AMF) generated by external coils to eradicate biofilm on the surface of medical implants, the firm's device enables doctors to address major complications of various surgeries, such as knee and hip replacements, as well as the plates and rods that define trauma-related implants. Using technology invented at the University of Texas Southwestern, Solenic is leveraging the unique properties of alternating magnetic fields (AMF) generated by external coils to eradicate biofilm on the surface of medical implants. This non-invasive treatment addresses a major complication of various surgeries such as knee and hip replacements, as well as in trauma related implants such as plates and rods. This is particularly important given an aging population and the rapid increase in the number of these procedures being performed every year.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,342,571
Project Title: Noninvasive Treatment of Biofilm on Metallic Implants

Key People / Management

  James Lancaster -- Co-Founder, Chief Executive

  Rajiv Chopra -- Co-Founder and CTO

  David Elihu Greenberg -- CoFounder and CMO

  John Tepper -- Vice President, Engineering

  Mark Wagstaff

Company News

There are no news available.